Amferia
Amferia develops medical devices and antimicrobial hydrogel dressings that utilize antimicrobial peptides to kill bacteria by mimicking the human immune system. The company provides non-toxic wound care solutions for both human healthcare and animal health markets. Their platform technology is also applied to pre-surgery treatments, antimicrobial sprays, and antibacterial coatings.
Visit websiteGothenburg, Sweden
Healthtech
Medical Devices
Biotechnology
Veterinary
Funding summary
- Total raised
- €2.6M
- Funding rounds
- 2
Investors in Amferia
Investors on record for Amferia. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Amferia?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors